RecallDepth
Class II Terminated

Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare Cop/Novartis, Deerfield, IL 60015, Manufactured by:Alza Corporation, Vacaville, CA 95688 for Novartis Consumer Health Inc., Parsippany, NJ 07054

This recall has been terminated (originally issued November 16, 2016).

Company
Sandoz Inc
Recall Initiated
August 24, 2016
Posted
November 16, 2016
Recall Number
D-0133-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
42,740 cartons (24 count carton from 7 total lots)
Firm Location
Princeton, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application.

Distribution

TN

Lot / Code Info

NDC 10019-553-02 (24 ct. carton) and NDC 10019-553-88 (patch); Lot #'s FV5908 and FX1520 both with expiry 06/2018; GB4910 and GC4210 both with expiry 09/2018; GE1927 with expiry 12/2018; GF7017 with expiry 01/2019 and GH8065 with expiry 02/2019.

More recalls by Sandoz Inc

View all recalls by this company →

Other recent Class II Drug recalls